Mode
Text Size
Log in / Sign up

Meta-analysis of VELscope diagnostic accuracy for oral potentially malignant disorders

Meta-analysis of VELscope diagnostic accuracy for oral potentially malignant disorders
Photo by Cht Gsml / Unsplash
Key Takeaway
Consider VELscope as an adjunctive tool for OPMD screening, noting its limited specificity and high heterogeneity in pooled estimates.

This is a meta-analysis of 24 prospective and cross-sectional studies evaluating the diagnostic accuracy of VELscope for oral potentially malignant disorders (OPMD). The primary synthesis focused on sensitivity, specificity, likelihood ratios, and the summary receiver operating characteristic (SROC) curve.

The authors found a pooled sensitivity of 84% (95% CI, 0.78–0.89; I² = 78.0%) and a pooled specificity of 45% (95% CI, 0.33–0.59; I² = 93.8%). The positive likelihood ratio was 1.55 (95% CI, 1.22–1.96; I² = 86.9%), and the area under the SROC curve was 0.78 (95% CI, 0.74–0.81). The negative likelihood ratio was not reported.

The authors note significant limitations, including high heterogeneity (I² > 75% for sensitivity, specificity, and positive likelihood ratio) and the influence of study design, indexing, and risk of bias on sensitivity. The abstract does not specify the reference standard used for diagnosis, and the specificity of VELscope is limited at 45%.

The authors suggest VELscope may serve as an adjunctive tool for OPMD detection in large-scale screenings, community oral examinations, and resource-limited settings, but not for standalone definitive diagnosis. Practice relevance is restrained due to the diagnostic accuracy limitations.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
This study aimed to evaluate the diagnostic efficacy of VELscope in detecting oral potentially malignant disorders (OPMD). A systematic search was conducted across six English databases and two Chinese databases: Embase, Web of Science, PubMed, Scopus, Dentistry & Oral Sciences Source (EBSCO), CINAHL (EBSCO), China National Knowledge Infrastructure (CNKI), and Chinese biomedical literature service system (SinoMed). Prospective and cross-sectional studies using VELscope to diagnose OPMD were included. Study quality was assessed using QUADAS-2. The meta-analysis evaluated VELscope's sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and the summary receiver operating characteristic (SROC) curve. Heterogeneity was assessed via Deeks’ funnel plot asymmetry test, bivariate boxplot, and meta-regression analysis to identify sources of variation. A total of 2054 studies were retrieved, of which 24 were included in the meta-analysis. The sensitivity of VELscope was 84% (95% CI, 0.78–0.89; I2 = 78.0%), specificity was 45% (95% CI, 0.33–0.59; I2 = 93.8%), and the positive likelihood ratio was 1.55 (95% CI, 1.22–1.96; I2 = 86.9%). The area under the SROC curve was 0.78 (95% CI, 0.74–0.81). Subgroup analysis indicated that SCIE indexing, comparative study design, and high risk of bias influenced the sensitivity of VELscope. The VELscope demonstrates high sensitivity but limited specificity in diagnosing OPMD. Although it is unreasonable to rely solely on VELscope for a definitive diagnosis, it can provide valuable adjunctive support for detecting OPMD in settings such as large-scale screenings, community oral examinations, and resource-limited environments.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.